Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05169437
Title Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors (PAVO)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tempus Labs
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.